BSX Financials
Boston Scientific Corp - Financial statements & key metrics
Stock Price
$76.85
Market Cap
$112.40B
P/E Ratio
39.0
EPS
$1.94
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$16.75B
Gross Profit
-
Operating Income
-
Net Income
$1.85B
EPS (Diluted)
$1.25
Balance Sheet Highlights
Total Assets
$39.40B
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$414.00M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$3.44B
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
68.8%
Operating Margin
0.2%
Net Margin
0.1%
ROE
0.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is BSX revenue?
BSX's most recent quarterly revenue was $16.75B. Annual revenue can be calculated by summing the four most recent quarters.
Is BSX profitable?
BSX reported a profit of $1.85B in the most recent quarter. The net profit margin is 0.1%.
What is BSX market cap?
BSX has a market capitalization of $112.40B, making it a large-cap stock.
Does BSX have debt?
View BSX's balance sheet for debt information.
What is BSX cash flow?
Cash flow data is available in the full financial statements.